#	Pagina
attuale pagina	/open-h2020/projects/217946/index.html
-1	/open-consip/fornitori/2018/profilo-00977870708/index.html
-2	/open-consip/fornitori/2017/profilo-01093240297/index.html
-3	/open-consip/fornitori/2017/profilo-03019450737/index.html
-4	/open-h2020/per-topic/mpue/list/index.html
-5	/open-h2020/per-topic/callosal/list/index.html
-6	/open-h2020/projects/215347/index.html
-7	/open-h2020/per-topic/i2b2/list/index.html
-8	/open-consip/fornitori/2016/profilo-01678870708/index.html
-9	/open-h2020/projects/205044/index.html
-10	/open-h2020/projects/197917/index.html

Opendata, web and dolomites

VacPath SIGNED

Novel vaccine vectors to resist pathogen challenge

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

VacPath project word cloud

Explore the words cloud of the VacPath project. It provides you a very rough idea of what is the project "VacPath" about.

responsive too economies esr stage spread world prophylactic safe models academia educate vectors construct health perceived diverse raised possibilities cooperate infection poses insufficient danger persistence training creative constant transmitted cell unravel rapid plasmid enter solutions globe infectious immune resistance disease academic private ready pathogens cellular innovative industry force nevertheless efficacy preclinical intracellular virus bacterial molecular infections vaccine combated sexually exploited bacterium threat immunity induce optimisation antibiotics vector vaccinate humans mediated back frequently uncover re diseases underlying urging humoral vaccines hampers demand burden populations chlamydia ago combination imposed mechanisms scientists obligate pathogen barely generation induction trachomatis protective

Project "VacPath" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITEIT UTRECHT Organization address address: HEIDELBERGLAAN 8 city: UTRECHT postcode: 3584 CS website: www.uu.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Total cost	2˙701˙874 €
EC max contribution	2˙701˙874 € (100%)
Programme	1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
Code Call	H2020-MSCA-ITN-2018
Funding Scheme	MSCA-ITN-ETN
Starting year	2019
Duration (year-month-day)	from 2019-01-01 to 2022-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITEIT UTRECHT UNIVERSITEIT UTRECHT Organization address address: HEIDELBERGLAAN 8 city: UTRECHT postcode: 3584 CS website: www.uu.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (UTRECHT)	coordinator	531˙239.00
2	UNIVERSITAT BASEL UNIVERSITAT BASEL Organization address address: PETERSPLATZ 1 city: BASEL postcode: 4051 website: www.unibas.ch contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BASEL)	participant	562˙553.00
3	HEINRICH-HEINE-UNIVERSITAET DUESSELDORF HEINRICH-HEINE-UNIVERSITAET DUESSELDORF Organization address address: UNIVERSITAETSSTRASSE 1 city: DUSSELDORF postcode: 40225 website: www.uni-duesseldorf.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (DUSSELDORF)	participant	505˙576.00
4	STATENS SERUM INSTITUT STATENS SERUM INSTITUT Organization address address: ARTILLERIVEJ 5 city: KOBENHAVN S postcode: 2300 website: www.ssi.dk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN S)	participant	297˙522.00
5	ABERA BIOSCIENCE AB ABERA BIOSCIENCE AB Organization address address: STUREPLAN 15 city: STOCKHOLM postcode: 11145 website: www.aberabio.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	281˙982.00
6	MICROBIOTEC SRL MICROBIOTEC SRL Organization address address: VIA DELLE VIGNE 12 city: MONTERIGGIONI postcode: 53035 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (MONTERIGGIONI)	participant	261˙499.00
7	UNIVERSITA DEGLI STUDI DI SIENA UNIVERSITA DEGLI STUDI DI SIENA Organization address address: VIA BANCHI DI SOTTO 55 city: SIENA postcode: 53100 website: www.unisi.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (SIENA)	participant	261˙499.00
8	SCLAVO VACCINES ASSOCIATION SCLAVO VACCINES ASSOCIATION Organization address address: PIAZZA LA LIZZA 7 city: SIENA postcode: 53100 website: www.sclavo.org/home contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (SIENA)	partner	0.00

Map

Project objective

Infectious diseases are a major burden and constant threat to European populations and economies. While barely perceived as a danger not too long ago, a combination of potential rapid spread of novel pathogens across the globe, antibiotics resistance, a come-back of “old” pathogens and persistence of yet to be combated pathogens has raised the demand for effective but safe vaccines. An example of a yet to be combated pathogen is the obligate intracellular bacterium Chlamydia trachomatis. This pathogen is the major cause of sexually transmitted bacterial disease in humans, and poses a world-wide health concern. While responsive to antibiotics, re-infections frequently occur, urging the need for a prophylactic vaccine. Nevertheless, insufficient knowledge on how to vaccinate against intracellular pathogens hampers the development of such vaccines. In the proposed project, 5 academic and 2 private partners will cooperate to educate early stage researchers (ESR) in the diverse aspects of novel vaccine development. ESR will design and construct innovative and safe virus-, bacterium-, and plasmid-based vaccine vectors that induce both cell-mediated and humoral immunity, to control infections with intracellular pathogens. They will test these vaccines and improve their efficacy in preclinical models of C. trachomatis infection, and unravel the cellular and molecular mechanisms underlying the induction of protective immune responses, to uncover possibilities for general vaccine vector optimisation. The end-result will be a new generation of safe vaccine vectors that can be exploited to vaccinate against C. trachomatis, and can be adapted to vaccinate against further intracellular pathogens of choice. Moreover, this project will educate a new generation of scientists that, through the offered, integrated training, will be ready to enter the European task force, in academia or industry, to find creative solutions to future pathogen-imposed challenges.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VACPATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VACPATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More